Gastroenterology | Dubai | UAE | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Finding latest examination of Gastro issues and digestive related disorders.

- Gastroenterology 2022

Welcome Message

We are pleased to extend a warm invitation to all interested parties to participate in the 4th International Conference on Gastroenterology and Digestive Disorders, scheduled to be held on December 09-10, 2022, in Dubai, UAE. The conference theme "Finding the Latest Examination of Gastro Issues and Digestive Related Disorders" promises to be an informative and enlightening event.

Gastroenterology 2022 will feature renowned speakers, principal investigators, experts, and researchers from the academic and healthcare sectors. Attendees can expect a rich program, including seminars, symposiums, and workshops covering the most recent therapeutic developments in various digestive disorder illnesses. The conference will also showcase talks by distinguished surgeons, gastroenterologists, endocrinologists, and aspiring young researchers.

The conference offers an exceptional opportunity for leading scientists, business leaders, and investors in the field to share ideas and perspectives, and for field delegates to engage with international experts. Interested participants are encouraged to register for Gastroenterologist 2023 with their colleagues.

We look forward to hosting a remarkable academic event, "Discovering Recent Developments of Gastroenterology and Digestive Disorders" on December 09-10, 2022, in Dubai, UAE.

Join us and network with peers while exploring the beautiful city of Dubai.

About

We cordially invite you to the upcoming "4th International Conference on Gastroenterology and Digestive Disorders" to be held on December 09-10, 2022, in Dubai, UAE, organized by Allied Academies.

Gastroenterology 2022 aims to foster collaborations and networking opportunities among Directors, Researchers, Professors, and Scholars from academia and industry from over 50 countries. The conference is themed around "Finding the Latest Examination of Gastro Issues and Digestive Related Disorders" and seeks to accelerate scientific discoveries and breakthroughs in the Gastroenterology and Digestive Disorders field.

The conference's objective is to bring together researchers in the field of Gastrologist, Anaesthesiologists, Professors, Surgeons, and Oncologists to explore the most recent developments and concepts and to facilitate interdisciplinary connections.

This conference provides an excellent opportunity for attendees to gain insights and learn about advancements in Gastro disorders from members all over the world. As a participant, you can present your research findings, distribute information, meet current and potential scientists, make an impact with discoveries in neurological treatment and diagnosis, and establish name recognition.

The conference features world-renowned speakers, cutting-edge techniques, developments, and the latest updates in the neurological disorders and treatments field. At Allied Group, we prioritize providing maximum exposure to our attendees; thus, we ensure that the event includes a diverse range of professionals such as neurosurgeons, scientists, neurologists, doctors, professors, and diagnostic laboratory professionals from academia.

We look forward to welcoming you to the "4th International Conference on Gastroenterology and Digestive Disorders" on December 09-10, 2022, in Dubai, UAE.

Target Audience:

Gastrologist
Anaesthesiologists
Oncologists
Professors
Surgeons
Scholars
Professionals in Diagnostic Laboratories
Directors, CEO of Organizations
Association, Association presidents and professionals
Noble laureates in Health Care and Medicine
Students Delegates

Market Analysis

The gastrointestinal pharmaceutical market is classified into prescription and over-the-counter medications, while the gastrointestinal diagnostics, testing, and vaccines market is categorized into diagnostics and testing, medical devices (such as endoscopy), and vaccines. The global gastrointestinal therapeutics market is expected to reach a value of USD 13.8 billion by 2026, with a CAGR of 6.5% from 2022 to 2026. This growth is attributable to various factors, including increasing biologics consumption, tentative approval of late-stage molecules, development of novel therapies using innovative technologies and improved diagnostic tools, and an increasing treatment-seeking population.

The rising number of gastric surgeries worldwide has directly impacted the growth of post-surgical gastroparesis cases, thereby driving the gastroparesis drugs market over the next few years. This growth factor is expected to drive the global gastroparesis drugs market by USD 940 million between 2023 and 2027, surpassing USD 7.1 billion by the end of the forecast period. Other factors driving this market's growth include unmet industry needs to increase R&D in the field and rising diabetes cases, which fuel the prevalence of diabetic gastroparesis.

One of the factors driving the growth of the gastrointestinal therapeutics market in the coming years is the increasing consumption of biologics for inflammatory bowel diseases (IBD). The global gastroparesis drugs market is expected to grow at a CAGR of 3% between 2017 and 2027. Fast-track approvals and acquisitions to shift the market phase, as well as the introduction of novel methods for treating gastroparesis symptoms, are emerging trends that will gain traction during the forecast period and have a positive impact on market growth.

The global gastrointestinal endoscopic devices market was valued at approximately USD 5.6 billion in 2022 and is expected to reach approximately USD 8.5 billion by 2027, with a CAGR of 7.0% between 2023 and 2027. In 2022, the global market for gastrointestinal therapeutics and diagnostics was valued at $49.6 billion. This market is expected to grow at a CAGR of 4.3% from 2023 to 2027, reaching almost $51.8 billion in 2027. North America had the highest revenue generation in the Worldwide Gastrointestinal Medications Market Income by Region in 2023, with revenue of 17,288 US dollars Million, while the Middle East and Africa had the lowest revenue generation.

The global gastrointestinal devices market is expected to grow at a CAGR of 7.5%, from $9.35 billion in 2027 to $10.05 billion in 2026, and at a CAGR of 6.1% to $12.72 billion by 2026. This market comprises substances (associations, sole ownerships, and organizations) that sell gastrointestinal devices and related services, which diagnose and treat diseases affecting the digestive system or gastrointestinal tract.

Scientific Sessions/Tracks

Track 1: Colorectal cancer/polyps

Most colon tumors develop over time through a multistep process involving a series of histological, morphological, and genetic changes. It has enabled the screening and detection of early-stage precancerous polyps before they become cancerous in individuals at average risk for colorectal cancer (CRC), potentially leading to significant reductions in CRC incidence. Regular polyp detection and removal is the most effective way to avoid colon cancer.

Related Conferences:

Related Associations:

Gastroenterological Association of Thailand | Indian Society of Gastroenterology | Philippine Society of Gastroenterology | European Society of Coloproctology | European Helicobacter and Microbiota Study Group | European Society of Neuro-gastroenterology and Motility | National Association for Colitis and Crohn's Disease (NACC) | Crohn's and Colitis Foundation of America | Society of American Gastrointestinal and Endoscopic Surgeons | The Society of Gastroenterology Nurses and Associates

Associated Journals:

Related Societies:

British Society of Gastroenterology (BSG) | Hackensack Gastroenterology Associates | Northlake Gastroenterology Associates | Atlantic Gastroenterology Associates | Mississippi Gastroenterology Society | American Society for General Surgeons | European Helicobacter and Microbiota Study Group | European Society of Neuro-gastroenterology and Motility | Motility British Society of Gastroenterology | European Society of Gastrointestinal Endoscopy | European Society for Paediatric Gastroenterology.

Track 2: Endoscopy

A gastrointestinal endoscopy allows a doctor to examine the interior lining of the digestive tract. The most recent cutting-edge technological advancements have resulted in a real advancement in endoscopic imaging and may facilitate practice standardization. Artificial intelligence is one of the most rapidly evolving modalities, with recent studies providing real-time diagnoses and encouraging results in the first randomized trials of conventional endoscopic imaging. Advances in functional hypoxia imaging provide new opportunities for detecting neoplasia and assessing colitis. Three-dimensional volumetric imaging provides spatial information and has shown promise in detecting small polyps more effectively.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

American Society for Gastrointestinal Endoscopy | European Society for Paediatric Gastroenterology, Hepatology, and Nutrition | French National Society of Gastroenterology | Finnish Society of Gastroenterology | Hellenic Society of Gastroenterology | Polish Society of Gastroenterology | Netherlands Society of Gastroenterology | Irish Society of Gastroenterology | Lithuanian Society of Gastroenterology | British Society of Gastroenterology

Track 3: Gastroesophageal and Gastric disease

Gastroesophageal reflux sickness (GERD) is a complex problem that incorporates a group of conditions caused or exacerbated by gastroesophageal reflux that causes bleakness, essentially through irksome side effects. Non-erosive reflux infection, GERD excessive touchiness, low or high-grade esophagitis, Barrett's throat, reflux chest torment, laryngopharyngeal reflux, and disgorging predominant reflux are the most well-known GERD aggregates.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 4: Hepatology

Hepatology differs from other specialized medical disciplines in that it focuses on organs affected by hepatic disorders. The hepatic system is made up of the liver, pancreas, gallbladder, and biliary tract. Hepatology is related to gastroenterology because it involves parts of the gastrointestinal (GI) tract. Hepatology is frequently considered a subspecialty of gastroenterology because they both involve some of the same organs. A gastroenterologist can help with the diagnosis and treatment of similar diseases, but a hepatologist has a narrower focus.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 5: Pancreatic and biliary disease

Some of the most common digestive system disorders are hepatobiliary and pancreatic disorders. The hepatopancreatobiliary system has a complex embryological development and thus is prone to anomalies that can have adverse effects on body physiology, in addition to being associated with a range of acquired problems that require specialized training to treat surgically.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 6: Small bowel and colonic disease

Small intestinal obstruction refers to a partial or complete blockage of the small intestine. If the small bowel is functioning properly, digested items will continue to pass into the large intestine. A partial or complete obstruction in the small bowel may prevent contents from passing. As a result, waste materials and gases accumulate in the area above the blockage. It may also prevent the absorption of nutrients and fluids. Conditions affecting the intestines are referred to as "colonic illnesses." This field includes diseases such as irritable bowel syndrome (Crohn's disease and ulcerative colitis), diverticular disease, and colon cancer.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 7: Gastrointestinal hormones

Customary GI chemicals are discharged by epithelial cells covering the lumen of the stomach and small digestive system. Endocrinocytes, or chemical emitting cells, are mixed among a lot bigger number of epithelial cells, which discharge their items (corrosive, bodily fluid, and so forth) or draw supplements from the lumen. GI chemicals are delivered into the circulatory system and flow all through the body, impacting the capability of the intestinal system, liver, pancreas, cerebrum, and different organs. Chemicals, neuro peptides, and synapses all affect GI capability.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 8: Geriatric Gastroenterology

Patients over the age of 65 are more likely to develop oesophageal and gastric diseases, such as motility abnormalities, gastroesophageal reflux, reflux complications (such as Barrett's, dysplasia, and oesophageal cancer), gastric ulcers, and gastrointestinal bleeding. Lower GI issues such as pelvic floor abnormalities (including fecal incontinence), constipation, diarrheal illness, diverticular disease, inflammatory bowel disease, and colon cancer are also more common and atypical in the elderly. Malnutrition and obesity are major concerns among the elderly, who face unique dietary challenges.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 9: Inflammation and enteric infectious disease

The gastrointestinal parcel is excited as a complex natural reaction to hurt brought about by microorganisms, harmed cells, or aggravations. The intestinal system's cooperative microbiome is remembered to safeguard the stomach by killing undesirable boosts and advancing recuperation. Unhealthiest, deferred mental turn of events, expanded helplessness to other irresistible sicknesses, unfortunate oral immunization reaction, and expanded mortality risk have all been connected to intestinal brokenness because of diarrheal illness, parasitic diseases, changes in the stomach microbial climate, and different issues.

Related Conferences:

Associated Journals:

Related Societies:

Track 10: Gastrointestinal Malignancy

The most widely recognized kinds of gastrointestinal disease are the following: Oesophageal malignant growth, gastric disease (stomach malignant growth), colorectal malignant growth, pancreatic disease, and liver malignant growth are instances of tumors. More uncommon sorts incorporate neuroendocrine growths, gastrointestinal stromal growths, and butt-centric disease. Growths can likewise be brought about by hidden conditions like oesophageal reflux sickness, Helicobacter pylori contamination in the stomach, pancreatic diabetes, fiery gut illness (colon and rectum), hepatitis B or C infection disease, or liver cirrhosis. Acquired gastrointestinal malignant growths make up a little level of all tumors.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 11: Gastrointestinal Motility

GI motility alludes to the development of food from the mouth through the pharynx (throat), throat, stomach, little and digestive organs, and out of the body. Fasting (interdigitate) constriction designs and postprandial (stomach-related) compression designs are two kinds of GI motility that change with a dinner. Smooth muscle contractility, outward and inborn neurons (engine and tangible), and certain chemicals all impact GI motility. In well-evolved creatures, ghrelin (GHRL) and motilin (MLN) advance yearning and GI motility while additionally helping with energy homeostasis.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 12: Gastroenterology

Among the most recent advances in gastroenterology, colonoscopy with artificial intelligence is associated with higher screening quality. Ozanimod seems to be an exciting salvage treatment in refractory UC, which still needs to be validated by Swiss medic. Rivaroxaban is the direct-acting anticoagulant most commonly associated with GI bleeding. The Chicago v4.0 classification of oesophageal motor disorders should be used in diagnostic management, as it was recently revised. Semaglutide appears to have promising results in the treatment of metabolic steatosis. Biliary tract disease can progress to hepatocellular failure and complicate SARS-CoV-2 infection. Track 13: Digestive Disorders

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 13: Liver Transplant

During a liver transplant, a failing liver is removed and replaced with a healthy liver from a deceased donor or a piece of a healthy liver from a living donor. A liver transplant is typically reserved for patients suffering from severe side effects from end-stage chronic liver disease. Transplantation is used to treat acute or chronic liver failure.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Track 14: Hepatitis

Hepatitis is a contamination of the liver that causes aggravation. Hepatitis is most ordinarily brought about by a viral disease; however, it tends to be brought about by different variables. Atherosclerotic hepatitis and hepatitis brought about by prescriptions, medications, poisons, or liquor are two models. Immune system hepatitis is a condition wherein your body produces antibodies that assault liver tissue. Hepatitis A, B, C, D, and E are viral liver sicknesses that are named hepatitis. Hepatitis An is generally a serious, momentary disease, while hepatitis B, C, and Dare are bound to be ongoing and industrious. Hepatitis E is normally deadly, yet it very well may be particularly hazardous in pregnant ladies.

Related Conferences:

Related Associations:

Associated Journals:

Related Societies:

Organizing committee members

Dr. Werner Scheithauer, PhD

Professor, INTERNAL MEDICINE

Medical University of Vienna, Austria

Larry Good, PhD

CEO, Good Pharmaceutical Development Company

The Medical University of South Carolina, USA

Olena Grechanina, PhD

Professor, Medical Genetics

Kharkiv Medical Academy of Postgraduate Education, Ukraine

Renowned Speakers

Dr. Ahmed Farag, PhD

Internal Medicine

Cairo University, Egypt

To Collaborate Scientific Professionals around the World

Conference Date	December 09-10, 2022
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Dr Shamsul Islam

QE II Jubilee Hospital, Kesdsels Roaf, Coopers Plains, Brisbane, Australia

I attended the gastroenterology conference and was blown away by the quality of the speakers and the depth of knowledge shared. As a practicing gastroenterologist, I learned new insights and techniques that I can apply in my practice immediately.<

Dr Ali Hasan

Al Qulayaa Area Corniche Street , Near Sharjah Supreme Council, Bin Taryam Building

The gastroenterology conference was an excellent opportunity to connect with colleagues from around the world and share best practices. I found the workshops to be particularly helpful in developing my skills and knowledge. Overall, it was an enri

Prof Higinio Mappala

Tower 1 Avida Towers-San Lazaro, F. Huertas St. Sta. Cruz, Manila, Philippines 1003

The gastroenterology conference was a fantastic opportunity to learn about the latest research and treatments in the field. The speakers were engaging, and the sessions were well-structured and informative. I especially appreciated the opportunity

Prof Maha Maher

Specialized Medical Hospital, Mansoura, Egypt

I have been attending the gastroenterology conference for several years now, and each time it exceeds my expectations. The conference is well-organized, and the topics covered are always relevant and up-to-date. I highly recommend it to anyone loo